Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
developmental code PNB-0408) is a synthetic small oligopeptide derived from angiotensin IV (AngIV), engineered to overcome AngIV's limitations as a research tool by adding lipophilic modifications that confer oral bioavailability and blood-brain barrier permeability
Plans typically require upfront payment
The 2025 Sports Health systematic review noted that 7 of 12 patients in a related protocol reported relief lasting more than 6 months
Most high-quality supplements use the reduced form (GSH) because it is the only state in which the molecule can perform its antioxidant duties
Start your consultation to ensure MOTS-c is compatible with your current treatments
Before making any changes to your routine, we always recommend a quick check-in with your family doctor or a qualified healthcare professional
US$ 22.37
US$ 22.04
US$ 29.91
US$ 20.31
US$ 25.59
